Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sana Biotechnology
Sana Biotechnology
Sana to lay off staff, deepen autoimmune focus in latest retrenchment
BioPharma Dive
Tue, 11/5/24 - 09:58 am
Sana Biotechnology
layoffs
autoimmune disease
Orbital shows 2023’s venture funding scene is far from stratospheric
EP Vantage
Fri, 05/19/23 - 10:06 am
RNA
funding
venture capital
Altos Labs
CureVac
EQRx
Hasten Biopharmaceutic
Orbital Therapeutics
Sana Biotechnology
Suzhou Abogen Biosciences
TORL BioTherapeutics
Sana lays off 15%, trims pipeline to keep funding flowing to off-the-shelf CAR-Ts
Fierce Biotech
Wed, 11/30/22 - 10:43 am
Sana Biotechnology
layoffs
CAR-T
cell therapy
Sana and BioLife Tout BioForest Region as Best Place to Work
BioSpace
Wed, 11/16/22 - 10:25 am
Sana Biotechnology
BioLife Solutions
BioForest
biotech hubs
Seattle
Seattle’s Sana Biotech Shifts Manufacturing to Bothell, Washington, Adds Key Leaders
BioSpace
Thu, 06/2/22 - 10:25 am
Seattle
Sana Biotechnology
California
drug manufacturing
3 Biotechs That Will Soar Regardless of COVID-19
Motley Fool
Thu, 01/27/22 - 11:39 pm
COVID-19
10x Genomics
Pieris
Sana Biotechnology
Cell therapy, AI drug discovery highlight 2021’s record year in biotech IPOs
MedCity News
Fri, 12/31/21 - 11:04 am
IPOs
cell therapy
artificial intelligence
Sana Biotechnology
Lyell Immunopharma
Caribou Biosciences
Instil Bio
Talaris Therapeutics
Achilles Therapeutics
Life Sciences Companies Ringing the Nasdaq Bell this Week
BioSpace
Thu, 02/4/21 - 08:10 pm
IPOs
NASDAQ
Sana Biotechnology
Sensei Biotherapeutics
Landos Biopharma
Aspira Women's Health
Equillium
Cell therapy biotech Sana Biotechnology prices further upsized IPO at $25, above the upwardly revised range
Renaissance Capital
Thu, 02/4/21 - 10:38 am
IPOs
Sana Biotechnology
cell therapy
IPO tracker: 2021 gets started with a flurry of new offerings
Endpoints
Mon, 01/25/21 - 10:43 am
IPOs
Sana Biotechnology
Sensei Biotherapeutics
Bolt Biotherapeutics
Immunocore
Terns Pharmaceuticals
Pharvaris
Vor Biopharma
Adagene
NexImmune
Biophytis
Gracell Biotechnologies
Cullinan Oncology
Sana Bio's $150 Million IPO Expected to Provide Market Valuation of $10 Billion
BioSpace
Tue, 01/19/21 - 10:53 am
Sana Biotechnology
IPOs
Emerging Seattle-Based Sana Biotechnology Seeks to Raise $150 Million IPO
BioSpace
Wed, 01/13/21 - 11:53 pm
IPOs
Sana Biotechnology
Biopharma Companies Continue to Expand, Add Jobs Despite Ongoing Pandemic
BioSpace
Tue, 06/30/20 - 11:44 pm
pharma industry
biotech
pandemic
COVID-19
hirings
AGC Biologics
Grail
Grifols
CRISPR Therapeutics
Sana Biotechnology
Point
Sanofi
Medpharm
Regeneron
Sana Biotechnology raises more than $700M for cell, gene therapy efforts
MedCity News
Tue, 06/23/20 - 10:42 am
Sana Biotechnology
Juno Therapeutics
CAR-T
Biotech’s newborn unicorn Sana grabs Harvard tech aimed at slipping engineered stem cells past the immune system
Endpoints
Tue, 03/26/19 - 11:13 pm
Sana Biotechnology
CAR-T
cell therapies
Harvard
Ex-Juno execs launch cell therapy start-up Sana
BioCentury
Sat, 01/5/19 - 12:07 am
Sana Biotechnology
R&D
cell therapy
gene therapy
Juno Therapeutics